These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24485876)

  • 21. Reprogramming the tumor microenvironment to enhance adoptive cellular therapy.
    Beavis PA; Slaney CY; Kershaw MH; Gyorki D; Neeson PJ; Darcy PK
    Semin Immunol; 2016 Feb; 28(1):64-72. PubMed ID: 26611350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic.
    Duong CP; Yong CS; Kershaw MH; Slaney CY; Darcy PK
    Mol Immunol; 2015 Oct; 67(2 Pt A):46-57. PubMed ID: 25595028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New directions in immunotherapy for malignant solid tumors].
    Okuno K; Sugiura F; Sukegawa Y; Inoue K
    Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?
    Thanendrarajan S; Nowak M; Abken H; Schmidt-Wolf IG
    Leuk Res; 2011 Sep; 35(9):1136-42. PubMed ID: 21652069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic-cell-based therapeutic cancer vaccines.
    Palucka K; Banchereau J
    Immunity; 2013 Jul; 39(1):38-48. PubMed ID: 23890062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The surgeon's role in immunotherapy.
    Sticca RP; Sticca JA
    Surg Oncol Clin N Am; 2007 Oct; 16(4):833-9, ix. PubMed ID: 18022547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of dendritic cells for the immunotherapy of tumors].
    Weise JB; Maune S; Kabelitz D; Heiser A
    HNO; 2005 Feb; 53(2):117-20. PubMed ID: 15657753
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunotherapy and the development of cancer vaccines.
    Dalgleish AG
    Expert Rev Vaccines; 2006 Feb; 5(1):1-4. PubMed ID: 16451100
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy.
    Fucà G; Spagnoletti A; Ambrosini M; de Braud F; Di Nicola M
    ESMO Open; 2021 Feb; 6(1):100046. PubMed ID: 33508733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment.
    Rodríguez Pérez Á; Campillo-Davo D; Van Tendeloo VFI; Benítez-Ribas D
    Clin Transl Oncol; 2020 Nov; 22(11):1923-1937. PubMed ID: 32266674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapeutic Approaches to Head and Neck Cancer.
    Nasser H; St John M
    Crit Rev Oncog; 2018; 23(3-4):161-171. PubMed ID: 30311572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoptive T-Cell Therapy for Cancer.
    Yang JC; Rosenberg SA
    Adv Immunol; 2016; 130():279-94. PubMed ID: 26923004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing adoptive T cell immunotherapy with microRNA therapeutics.
    Ji Y; Hocker JD; Gattinoni L
    Semin Immunol; 2016 Feb; 28(1):45-53. PubMed ID: 26710685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From concept to clinic: Mathematically informed immunotherapy.
    Walker R; Enderling H
    Curr Probl Cancer; 2016; 40(1):68-83. PubMed ID: 26645497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.
    Morisaki T; Matsumoto K; Onishi H; Kuroki H; Baba E; Tasaki A; Kubo M; Nakamura M; Inaba S; Yamaguchi K; Tanaka M; Katano M
    Hum Cell; 2003 Dec; 16(4):175-82. PubMed ID: 15147037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
    Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
    Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy.
    Lei X; Lei Y; Li JK; Du WX; Li RG; Yang J; Li J; Li F; Tan HB
    Cancer Lett; 2020 Feb; 470():126-133. PubMed ID: 31730903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Progress in CAR-T Cell Therapy for Solid Tumors.
    Ma S; Li X; Wang X; Cheng L; Li Z; Zhang C; Ye Z; Qian Q
    Int J Biol Sci; 2019; 15(12):2548-2560. PubMed ID: 31754328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immuno-cell therapy of cancer in Japan.
    Egawa K
    Anticancer Res; 2004; 24(5C):3321-6. PubMed ID: 15515427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adoptive immunotherapy: evaluation and perspectives in the treatment of certain cancers].
    Bartholeyns J; Bardot V; Chokri M; Romet-Lemonne JL
    Rev Med Interne; 2000 Oct; 21(10):863-71. PubMed ID: 11075395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.